MGTX - MeiraGTx Holdings plc
IEX Last Trade
6.15
0.020 0.325%
Share volume: 6,794
Last Updated: Fri 27 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$6.13
0.02
0.33%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-11 | 2022-11-10 | 2023-03-14 | 2023-05-11 | 2023-08-10 | 2023-11-14 | 2024-03-15 | 2024-05-09 | |
Total revenue | 10.759 M | 4.816 M | -5.288 M | 3.334 M | 3.540 M | 5.103 M | 2.040 M | 697.000 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 10.759 M | 4.816 M | -5.288 M | 3.334 M | 3.540 M | 5.103 M | 2.040 M | 697.000 K | |
-55.24% | -209.80% | 163.05% | 6.18% | 44.15% | -60.02% | -65.83% | |||
Operating expenses | 34.517 M | 27.624 M | 35.767 M | 35.094 M | 32.325 M | 37.865 M | 45.794 M | 47.469 M | |
Selling general and admin | 10.518 M | 10.762 M | 14.002 M | 12.772 M | 12.388 M | 10.009 M | 12.124 M | 13.147 M | |
Research and development | 23.999 M | 16.862 M | 21.765 M | 22.322 M | 19.937 M | 27.856 M | 33.670 M | 34.322 M | |
Total expenses | 34.517 M | 27.624 M | 35.767 M | 35.094 M | 32.325 M | 37.865 M | 45.794 M | 47.469 M | |
-19.97% | 29.48% | -1.88% | -7.89% | 17.14% | 20.94% | 3.66% | |||
Operating income | -23.758 M | -22.808 M | -41.055 M | -31.760 M | -28.785 M | -32.762 M | -43.754 M | -46.772 M | |
Ebit | -23.758 M | -22.808 M | -41.055 M | -31.760 M | -28.785 M | -32.762 M | -43.754 M | -46.772 M | |
Pretax income | -33.973 M | -37.284 M | -27.313 M | -30.364 M | -29.581 M | -44.297 M | 20.215 M | -20.442 M | |
9.75% | -26.74% | 11.17% | -2.58% | 49.75% | -145.64% | -201.12% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -33.973 M | -37.284 M | -27.313 M | -30.364 M | -29.581 M | -44.297 M | 20.215 M | -20.442 M | |
-9.75% | 26.74% | -11.17% | 2.58% | -49.75% | 145.64% | -201.12% | |||
Net income | -33.973 M | -37.284 M | -27.313 M | -30.364 M | -29.581 M | -44.297 M | 20.215 M | -20.442 M | |
-9.75% | 26.74% | -11.17% | 2.58% | -49.75% | 145.64% | -201.12% |